Paradoxical psoriasis: an updated review of clinical features, pathogenesis, and treatment options
CA Maronese, M Valenti, C Moltrasio… - Journal of Investigative …, 2024 - Elsevier
The definition of paradoxical psoriasis (PP) encompasses 2 main scenarios, namely,(i) new-
onset psoriasis in patients treated for a different disease and (ii) worsening as well as …
onset psoriasis in patients treated for a different disease and (ii) worsening as well as …
Paradoxical psoriasis induced by IL-17 inhibitors: a case series of patients with axial spondyloarthritis and a systematic literature review
N Chaitidis, Z Papadopoulou, ST Varvara… - Rheumatology …, 2024 - Springer
Following the market authorization of interleukin (IL)-17 inhibitors, a growing number of
cases of IL-17 inhibitor-induced paradoxical psoriasis (PsO) have been reported. Our …
cases of IL-17 inhibitor-induced paradoxical psoriasis (PsO) have been reported. Our …
The dark side of the moon: the immune-mediated adverse events of IL-17A/IL-17R inhibition
F Messina, S Piaserico - Journal of Dermatological Treatment, 2022 - Taylor & Francis
As aberrant IL-17 signaling plays a critical role in the pathogenesis of psoriasis, biologic
agents targeting this pathway have become an important weapon against this disease …
agents targeting this pathway have become an important weapon against this disease …
[HTML][HTML] Paradoxical Psoriasis and Worsening Spondylitis Due to Secukinumab in a Patient With Ankylosing Spondylitis: A Case Report and Literature Review
KA Alnaqbi, J Al Zeyoudi, F Fazal, OM Alhaj, I Jassim… - Cureus, 2023 - ncbi.nlm.nih.gov
Axial spondyloarthritis (axSpA) is an autoimmune disease primarily affecting the axial
skeleton, with associated extra-musculoskeletal manifestations. Treatment strategies …
skeleton, with associated extra-musculoskeletal manifestations. Treatment strategies …
[PDF][PDF] Skin Related Paradoxical Adverse Events (Mainly Psoriasis) During Il-17 Blockage: A Systematic Review
AMG Brunasso, M Montinari - 2023 - scholar.archive.org
Abstract Background: Paradoxical Adverse Events (PAEs) during biological therapy are
characterized by the onset of a new inflammatory disease or by the exacerbation of the …
characterized by the onset of a new inflammatory disease or by the exacerbation of the …
[引用][C] Article Info Figures and Data
AMG Brunasso, M Montinari - athenaeumpub.com
Background: Paradoxical Adverse Events (PAEs) during biological therapy are
characterized by the onset of a new inflammatory disease or by the exacerbation of the …
characterized by the onset of a new inflammatory disease or by the exacerbation of the …
[PDF][PDF] Secukinumab-induced Oral Lichen Planus: A Report of Case and Review of Literature
Recent years, we are witnessing a more frequent use of biological agent treatments.
Secukinumab (SEC) has been used successfully in the management of psoriasis, psoriatic …
Secukinumab (SEC) has been used successfully in the management of psoriasis, psoriatic …
Response to:'Correspondence on 'Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF …
A Ciurea, R Micheroli - Annals of the rheumatic diseases, 2022 - ard.bmj.com
We would like to thank Huang et al 1 for their interest in our study 2 and the opportunity to
discuss some aspects in more detail. The limited sample size precluded subgroup analyses …
discuss some aspects in more detail. The limited sample size precluded subgroup analyses …